Tandem Diabetes Care (TNDM) Retained Earnings (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Retained Earnings of $5.0 million for Q1 2026, up 100.4% on a QoQ basis from -$1.3 billion in Q4 2025, and up 100.43% year-over-year from $2.5 million in Q1 2025.
Tandem Diabetes Care (TNDM) Retained Earnings (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Retained Earnings history runs 14 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- Quarterly Retained Earnings rose 100.43% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 100.43% YoY) and the FY2025 annual result came in at -$1.3 billion, down 64231.54% from the prior year.
- Retained Earnings was $5.0 million for Q1 2026 at Tandem Diabetes Care, up from -$1.3 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $5.2 million in Q3 2025 and bottomed at -$1.3 billion in Q4 2025.
- A 5-year average of -$475.0 million and a median of -$649.3 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 2291017.24% — and 2025, when it jumped 398.88%.
- Tandem Diabetes Care's Retained Earnings stood at -$729.2 million in 2022, then surged by 100.19% to $1.4 million in 2023, then plunged by 242.22% to -$1.9 million in 2024, then plunged by 64231.54% to -$1.3 billion in 2025, then jumped by 100.4% to $5.0 million in 2026.
- Business Quant data shows TNDM's Retained Earnings at $5.0 million in Q1 2026, -$1.3 billion in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | 5.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.04 Mn |
| Dec 31, 2025 | -1.25 Bn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | -1.18 Bn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -1.05 Bn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -994.52 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | -2.21 Mn |
| Jun 30, 2023 | -1.19 Mn |
| Mar 31, 2023 | -853.06 Mn |
| Dec 31, 2022 | -729.19 Mn |
| Sep 30, 2022 | -713.34 Mn |
| Jun 30, 2022 | -664.37 Mn |
| Mar 31, 2022 | -649.31 Mn |
| Dec 31, 2021 | -616,000.00 |
| Sep 30, 2021 | -645.40 Mn |
| Jun 30, 2021 | 29,000.00 |